课题基金 / 基金详情

MAD PHASING OF CORN INHIBITOR OF BLOOD COAGULATION FACTOR XIIA

MAD PHASING OF CORN INHIBITOR OF BLOOD COAGULATION FACTOR XIIA
玉米凝血因子 XIIA 抑制剂的 MAD 定相
批准号:
6437423
负责人:
Ronald E Stenkamp
金额:
$14.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-03-01 至 2002-02-28

项目摘要

项目成果

Ronald E Stenkamp的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We wish to use MAD phasing techniques to solve the crystal structure of a proteinase inhibitor (CHFI) which shows particular selectivity for the human blood coagulation Factor XIIa. Factor XII is part of the "contact system" of plasma, which after contacting appropriate surfaces, can lead to blood coagulation, activation of the complement system, fibrinolysis, or inflammation. The specificity of CHFI for factor XIIa makes it a useful reagent of potential importance in regulating any or all of these systems. The protein contains 127 residues and is readily crystallized. We have searched for heavy atom derivatives for use in multiple isomorphous replacement phasing attempts, but we have not found any useful derivatives. Molecule replacement methods using NMR structures of a related inhibitor have not been successful in solving this structure. The protein can be expressed in E. coli and grown with selenium-methionine substituting for the three methionines in the expressed protein.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STRUCTURAL STUDIES IN RHODOPSIN ACTIVATION AND RPE65
  • 批准号:
    8361643
  • 项目类别:
  • 资助金额:
    $1.65万
  • 财政年份:
    2011
  • 负责人:
    Ronald E Stenkamp
  • 依托单位:
CRYSTALLOGRAPHIC STRUCTURE ANALYSES OF PROTEIN/LIGAND COMPLEXES
  • 批准号:
    8362165
  • 项目类别:
  • 资助金额:
    $0.03万
  • 财政年份:
    2011
  • 负责人:
    Ronald E Stenkamp
  • 依托单位:
STRUCTURAL STUDIES OF RHODOPSIN
  • 批准号:
    8169267
  • 项目类别:
  • 资助金额:
    $1.05万
  • 财政年份:
    2010
  • 负责人:
    Ronald E Stenkamp
  • 依托单位:
CRYSTALLOGRAPHIC STRUCTURE ANALYSES OF PROTEIN/LIGAND COMPLEXES
  • 批准号:
    8170116
  • 项目类别:
  • 资助金额:
    $0.13万
  • 财政年份:
    2010
  • 负责人:
    Ronald E Stenkamp
  • 依托单位:
海外基金